MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$7,985
Unit: Dollar

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Sales
0 ---278*
Service revenue
25,000 37,500 --
Cost of revenues
0 0 --132*
Gross profit
25,000 37,500 --146*
General and administrative
30,885 40,620 32,277 19,774.5
Total operating expenses
30,885 40,620 32,277 19,774.5*
Operation income
-5,885 -3,120 -32,277 -19,920.5*
Interest expense
2,100 2,100 2,100 2,100*
Loss before income taxes
---34,377 -22,020.5
Income tax provision
0 ---
Net loss
-7,985 -5,220 -34,377 -22,020.5
Diluted EPS
--0 -0
Diluted Average Shares
96,433,333 96,433,333 99,000,000 99,000,000
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$7,985 Service revenue$25,000 Operation income-$5,885 (74.49%↑ Y/Y)Interest expense$2,100 Gross profit$25,000 Total operatingexpenses$30,885 (33.90%↑ Y/Y)General andadministrative$30,885 (33.90%↑ Y/Y)

GOLDENWELL BIOTECH, INC. (GWLL)

GOLDENWELL BIOTECH, INC. (GWLL)